Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib.
Zhang J, Zhu H, Shen L, Li J, Zhang X, Bai C, Zhou Z, Yu X, Li Z, Li E, Yuan X, Lou W, Chi Y, Xu N, Yin Y, Bai Y, Zhang T, Xiu D, Chen J, Qin S, Wang X, Yang Y, Shi H, Luo X, Fan S, Su W, Lu M, Xu J.
Zhang J, et al. Among authors: zhou z.
Chin J Cancer Res. 2023 Oct 30;35(5):526-535. doi: 10.21147/j.issn.1000-9604.2023.05.09.
Chin J Cancer Res. 2023.
PMID: 37969958
Free PMC article.